NO20073382L - Contrast Agents - Google Patents

Contrast Agents

Info

Publication number
NO20073382L
NO20073382L NO20073382A NO20073382A NO20073382L NO 20073382 L NO20073382 L NO 20073382L NO 20073382 A NO20073382 A NO 20073382A NO 20073382 A NO20073382 A NO 20073382A NO 20073382 L NO20073382 L NO 20073382L
Authority
NO
Norway
Prior art keywords
compounds
contrast agents
iodine
relates
diagnostic
Prior art date
Application number
NO20073382A
Other languages
English (en)
Inventor
Lars-Goran Wistrand
Duncan Wynn
Ian Martin Newington
Original Assignee
Ge Healthcare As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare As filed Critical Ge Healthcare As
Priority to NO20073382A priority Critical patent/NO20073382L/no
Priority to US12/664,905 priority patent/US20100189656A1/en
Priority to PCT/NO2008/000242 priority patent/WO2009005364A1/en
Publication of NO20073382L publication Critical patent/NO20073382L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having carbon atoms of carboxamide groups, amino groups and at least three atoms of bromine or iodine, bound to carbon atoms of the same non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Den foreliggende oppfinnelsen vedrører en klasse forbindelser som inneholder jod og diagnostiske sammensetninger inneholdende disse forbindelsene. Mer spesielt er de jodinneholdende forbindelsene kjemiske forbindelser som innehar en sentral trialkylamingruppe med tre joderte fenylgrupper bundet til seg. Oppfinnelsen vedrører også anvendelsen av diagnostiske sammensetninger som kontrastmidler i diagnostisk billeddannelse og mer spesielt til anvendelse i røntgen billeddannelse.
NO20073382A 2007-06-29 2007-06-29 Contrast Agents NO20073382L (no)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NO20073382A NO20073382L (no) 2007-06-29 2007-06-29 Contrast Agents
US12/664,905 US20100189656A1 (en) 2007-06-29 2008-06-27 Contrast agents
PCT/NO2008/000242 WO2009005364A1 (en) 2007-06-29 2008-06-27 Contrast agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20073382A NO20073382L (no) 2007-06-29 2007-06-29 Contrast Agents

Publications (1)

Publication Number Publication Date
NO20073382L true NO20073382L (no) 2008-12-30

Family

ID=39811637

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073382A NO20073382L (no) 2007-06-29 2007-06-29 Contrast Agents

Country Status (3)

Country Link
US (1) US20100189656A1 (no)
NO (1) NO20073382L (no)
WO (1) WO2009005364A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8480800B2 (en) * 2009-12-17 2013-07-09 ANGUS Chemical Company and Dow Global Technologies LLC Aminoalcohol compounds, precursors, and methods of preparation and use
CN104230731B (zh) * 2014-09-24 2016-01-20 武汉理工大学 造影剂中间体三碘异酞酰氯的制备方法
CN114436880B (zh) * 2020-11-03 2023-04-28 成都倍特药业股份有限公司 碘普罗胺中间体的制备方法
CN116143646A (zh) * 2023-01-03 2023-05-23 安庆朗坤药业有限公司 一种5-氨基-2,4,6-三碘异酞酰氯的纯化方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3378338A (en) * 1965-05-27 1968-04-16 Imp Smelting Corp Ltd Production of high-purity aluminium chloride
US3734953A (en) * 1969-08-11 1973-05-22 Squibb & Sons Inc Tris-triiodoisophthalamic acids and derivatives
US5019370A (en) * 1989-07-10 1991-05-28 University Of Kentucky Research Foundation Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging
FR2703055B1 (fr) * 1993-03-22 1995-07-07 Guerbet Sa Nouveaux composés polyiodés, leur préparation et leur utilisation en tant que produits de contraste pour la radiologie .
DE69425572T2 (de) * 1993-06-02 2001-04-26 Bracco Spa Iodierte paramagnetische chelaten, und deren verwendung als kontrastmittel
IT1264690B1 (it) * 1993-07-08 1996-10-04 Bracco Spa Compositi oligomeri iodurati e composizioni diagnostiche contenenti gli stessi
CA2566605A1 (en) * 2004-05-14 2005-12-01 Kenneth I. Sawyer Polyurea compositions and compounds for the preparation thereof
NO20055702D0 (no) * 2005-12-02 2005-12-02 Amersham Health As Contrast agents

Also Published As

Publication number Publication date
WO2009005364A1 (en) 2009-01-08
US20100189656A1 (en) 2010-07-29

Similar Documents

Publication Publication Date Title
DE602007012208D1 (de) Kontrastmittel
TN2009000063A1 (en) Compounds and methods for 18f labeled agents
CY1110813T1 (el) Χημικες ενωσεις
MA38143A1 (fr) Composition comprenant des agents de lutte biologique
MX2009010412A (es) Composiciones para formacion de imagen objetivo y terapia.
CY1118691T1 (el) Συνθεσεις και μεθοδοι χρησης για αντισωματα κατα σκληροστινης
UA103319C2 (en) Thiazole- and oxazole-benzene sulfonamide compounds
IL181529A0 (en) Diagnostic compounds
MX2011011661A (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
SG10201701868UA (en) Compositions comprising 2,3-dichloro-1,1,1-trifluoropropane, 2-chloro-1,1,1-trifluoropropene, 2 chloro-1,1,1,2-tetrafluoropropane or 2,3,3,3-tetrafluoropropene
EP2576540A4 (en) HEZEROARYL COMPOUNDS AND METHOD FOR USE THEREOF
CY1115078T1 (el) Παραγωγα πυραζολοαμινοπυριδινης χρησιμα ως αναστολεις της κινασης
SV2009003349A (es) Compuestos triciclicos, composiciones y procedimientos
BR112012021771A2 (pt) métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2.
CY1115919T1 (el) Ενωσεις ενεργοποιησης τελομερασης και μεθοδοι χρησης αυτων
EA200901142A1 (ru) 18f фторбензоильные меченые биологически активные соединения в качестве диагностических визуализирующих средств, а также бензотриазол-1-илоксибензоильные, 2,5-(диоксопирролидин-1-илокси)бензоильные и триметиламмониобензоильные предшественники
MA34951B1 (fr) Compositions pesticides et procedes associes
MA34057B1 (fr) Compositions et methodes pour le diagnostic et le traitement d'une tumeur
EP2528578A4 (en) DENTAL COMPOSITION USING A CALCIUM SOURCE
MX2010009184A (es) Proceso para la yodacion de compuestos aromaticos.
NO20084821L (no) Formuleringer og metoder for celleimaging og terapi
MX2013012793A (es) Aminoacidos radiomarcados para imagen de diagnostico.
NO20073382L (no) Contrast Agents
MX2009003617A (es) Derivados de silicio para obtencion de imagenes por tomografia de emision de positrones (pet).
UA98832C2 (ru) Композиции пестицидов и их применение